Author

O. El Naggar

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

A. J. Lazar· 1 shared C. Sell· 1 shared E. Noguchi· 1 shared F. Paradiso· 1 shared F. Taraballi· 1 shared G. Romano· 1 shared J. A. Wargo· 1 shared J. C. Costello· 1 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. J. Lazar

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell BiologybioRxivPreprintJul 7, 2022

lncRNA H19/Let7b/EZH2 axis regulates somatic cell senescence

M. Potnis, J. Do, O. El Naggar…·C. Sell

This study identifies the lncRNA H19/Let7b/EZH2 axis as a regulator of somatic cell senescence, showing H19 depletion leads to premature senescence and its role in modulating EZH2 levels.

DOI 10.1101/2022.07.07.499142

humanexperimental assay

𝕏 PostBluesky

Cancer BiologybioRxivMay 24, 2022

Microparticle-delivered Cxcl9 prolongs Braf inhibitor efficacy in melanoma

G. Romano, F. Paradiso, P. Li…·L. N. Kwong

The paper shows that delivering Cxcl9 via microparticles enhances the effectiveness of BRAF inhibitors in melanoma by reducing minimal residual disease relapse.

DOI 10.1158/2326-6066.cir-22-0224

mouseexperimental assay

𝕏 PostBluesky